FMP
NASDAQ
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.
0.29 USD
0.0023 (0.793%)
Dr. Meeshanthini V. Dogan Ph.D.
Healthcare
Biotechnology
NASDAQ
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.
0001870144
US14159C1036
14159C103
400 N Aberdeen St
855 226 9991
US
7
Jan 14, 2022
0001870144
NASDAQ
Biotechnology
Healthcare
14159C103
US14159C1036
US
0.29
4.81
233.51k
6.94M
-
0.171-3.56
-0
-
-
-
-
-0.72
-
https://cardiodiagnosticsinc.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.